Drugs / Salvinorin A
Salvinorin A
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00996411 | Nov 2008 → Nov 2013 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03418714 | Dec 2017 → Mar 2020 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01149824 | Jun → Dec 2009 | — | California Pacific Medical Center Research Institute | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT00700596 Comparator | Feb 2009 → Aug 2014 | — | Yale University | Completed | No outcome recorded |
| Phase 1 | NCT02033707 Background | Apr 2014 → Feb 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salvinorin A | “Hallucinogens: DMT, 4-phosphoryloloxy-N-diethyltryptamine, dipropyltryptamine (DPT), ketamine, dextromethorphan, mescaline, PCP, psilocybin, salvinorin-A, LSD, d-lysergic acid...” NCT02033707 ↗ |
| Known as | CHEMBL445332 | ChEMBL registry synonym — accepted as the source's own label CHEMBL445332 ↗ |
| Known as | DIVINORIN A | ChEMBL registry synonym — accepted as the source's own label CHEMBL445332 ↗ |
| Known as | SALVINORIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL445332 ↗ |
| Known as | SALVINORIN A (CRM) | ChEMBL registry synonym — accepted as the source's own label CHEMBL445332 ↗ |
| Modality | Small molecule | — CHEMBL445332 ↗ |
| Route | Inhaled | “An inhalation route of administration will be used” NCT03418714 ↗ |